Table 5. Two candidate modifier loci are associated with disease severity in the cohort.
Gene: | RPGRIP1 | RPGRIP1L | CEP290 | IQCB1 | ||||||||
cSNP: | P96Q | K192E | A547S | E1033Q | A229T | R744Q | G1025S | D1264N | K838E | L906W | I393N | C434Y |
P value all | 0.6224 | 0.3666 | 0.6835 | 0.2943 | 0.5637 | 0.0493 | 0.5227 | 0.9196 | 0.6984 | NA | 0.0438 | 0.9774 |
P value protein | 0.0768 | 0.3721 | 0.2230 | 0.3018 | 0.5637 | 0.2444 | 0.2383 | 0.2677 | 0.3483 | NA | 1.0000 | 0.4239 |
P value null | 0.0782 | 0.0834 | 0.1195 | 0.0770 | NA | 0.4551 | 0.7288 | 0.2572 | 0.1883 | NA | 0.0298 | 0.4870 |
P value ex 1–14 | 0.0707 | 0.0358 | 0.2658 | 0.0455 | 0.3173 | 0.3046 | 0.6687 | 0.5909 | 0.3046 | NA | 0.0176 | 0.2353 |
P value ORF15 | 0.0768 | 0.1706 | 0.0737 | 0.2528 | 1.0000 | 0.2444 | 0.6749 | 0.5318 | 0.3483 | NA | 1.0000 | 0.2296 |
Common coding SNPs in candidate modifier genes were tested for association with disease severity in the total cohort (“all” in left column) and in the subgroups with predicted translated RPGR protein (“protein” in left column), with predicted null alleles (“null” in left column), with exon 1–14 mutations (“ex 1–14” in left column), and with ORF15 mutations (“ORF15” in left column). P-values<0.05 are shown in bold.